The impact of diabetes on left ventricular diastolic function in patients with arterial hypertension

Murat Araz1, Aysen Bayrac2, Hilmi Ciftci3

  • 1Department of Medical Oncology, Malatya State Hospital, Malatya, Turkey.

Insights

Diabetes significantly worsens left ventricular diastolic function in patients with hypertension. This impact is observed in both men and women, highlighting a critical link between diabetes and cardiovascular health.

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Arterial hypertension and diabetes mellitus are significant risk factors for cardiovascular disease.
  • Left ventricular diastolic dysfunction is an early indicator of cardiac compromise.

Purpose of the Study:

  • To investigate the effect of diabetes mellitus on left ventricular diastolic function in patients with arterial hypertension.
  • To assess whether diabetes exacerbates diastolic dysfunction in hypertensive individuals.

Main Methods:

  • A cohort of 110 hypertensive patients (aged ≥40) were evaluated.
  • Transthoracic echocardiography assessed left ventricular diastolic function.
  • Patients with coronary artery disease or reduced ejection fraction were excluded.

Main Results:

  • Diastolic dysfunction was more prevalent in patients with diabetes (81.25%) compared to those without (62.9%).
  • The prevalence of diastolic dysfunction did not significantly differ between genders within the diabetic or non-diabetic groups.

Conclusions:

  • Diabetes mellitus negatively impacts left ventricular diastolic function in the presence of arterial hypertension.
  • This detrimental effect of diabetes on diastolic function is consistent across both male and female hypertensive patients.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
528
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
690